Parenteral methotrexate in psoriasis. A report on the efficacy and toxicity of long-term intermittent treatment.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001168:Arthritis / Q000188:drug therapy; D001219:Aspartate Aminotransferases / Q000097:blood; D055598:Chemical Phenomena; D002621:Chemistry; D003967:Diarrhea / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D007263:Infusions, Parenteral; D007408:Intestinal Absorption; D008103:Liver Cirrhosis / Q000139:chemically induced; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000633:toxicity; D009325:Nausea / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy*; D013281:Stomatitis, Aphthous / Q000139:chemically induced; D013997:Time Factors
D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D008727:Methotrexate